ProMIS Neurosciences, Inc. (PMN)
EBITDA Growth
-15.94%
Quarterly · Period ending:
PMN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-15.94%period ending
Latest reported-15.94%period ending
PMN Quarterly EBITDA YoY % (-438.43% → -15.94%)
Year-over-year change
High-resolution chart · PNG
PMN ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -15.9397% | |
| -17.6512% | |
| -79.4622% | |
| -224.842% | |
| -285.6079% | |
| -106.4996% | |
| -55.6402% | |
| 505.9637% | |
| 12.4287% | |
| 46.9359% | |
| 60.4861% | |
| 72.0041% | |
| 10.7564% | |
| -175.9862% | |
| -356.3578% | |
| -671.74% | |
| -3,394.1714% | |
| -247.82% | |
| -216.5137% | |
| 32.3111% | |
| 94.172% | |
| 60.3153% | |
| 53.3946% | |
| -26.416% | |
| -16.5526% | |
| 28.2224% | |
| 59.0379% | |
| 45.1325% | |
| 15.9581% | |
| -103.6411% | |
| -320.9939% | |
| -73.0031% | |
| -15.274% | |
| -17.375% | |
| 2.3526% | |
| -99.5678% | |
| -167.7263% | |
| -101.1765% | |
| -85.292% | |
| -23.8825% | |
| -156.0249% | |
| -61.2159% | |
| 10.4751% | |
| 15.8728% | |
| 76.7271% | |
| 57.7062% | |
| -27.8429% | |
| -40.3587% | |
| -61.1317% | |
| -24.5781% | |
| 17.5961% | |
| 21.3701% | |
| 1.203% | |
| 17.6792% | |
| 29.5927% | |
| -3.7423% | |
| -11.9971% | |
| 14.5794% | |
| 11.4734% | |
| -634.1471% | |
| 65.409% | |
| 33.2282% | |
| 25.3992% | |
| 108.7936% | |
| -52.5036% | |
| -34.8873% | |
| -35.6726% | |
| -13.4535% | |
| 36.316% | |
| 41.0448% | |
| 49.6454% | |
| 48.208% | |
| 7.5061% | |
| -1.4511% | |
| -112.4658% | |
| -189.6199% | |
| -143.6578% | |
| -213.2411% | |
| -85.2792% | |
| -195.638% | |
| -438.4328% |